Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016

BACKGROUND: Despite evidence shown of dolutegravir (DTG)-related neurotoxicity, which may be more common when combined with abacavir (ABC), its reversibility has not been explored in a clinical trial. METHODS: We conducted a randomized, multicenter, open-label, pilot trial to evaluate the reversibil...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Perez Valero, Ignacio, Cabello, Alfonso, Ryan, Pablo, De La Fuente-Moral, Sara, Santos, Ignacio, Vivancos, Maria Jesus, Gonzalez, Alicia, Gorgolas, Miguel, Cuevas, Guillermo, Diaz De Santiago, Alberto, Cano, Joanna, Rua, Guadalupe, Yllescas, Maria, González García, Juan Julian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Major Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727346/
https://ncbi.nlm.nih.gov/pubmed/33335931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa482
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak